🔎 Trials Near Me

Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › Rhode Island

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di Rhode Island

7 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi di Rhode Island.

Kota di Rhode Island

Teks studi resmi (Bahasa Inggris)

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Site #0132, Providence
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537

Head and Neck Cancer Study Project in the Geriatric Population

  • Rhode Island and The Miriam Hospitals, Providence
Menerima pesertaFase 3
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06998069

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT04777994

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • Women & Infants Hospital, Providence
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Nov 2025 · NCT05902988

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

  • Rhode Island Hospital, Providence
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Okt 2025 · NCT06699212

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Rhode Island Hospital, Providence
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.